ENDRA Life Sciences's market cap is currently $3.94M. The company's EPS TTM is $-1.71; its P/E ratio is ―; ENDRA Life Sciences is scheduled to report earnings on June 30, 2025, and the estimated EPS forecast is $-1.95. See an overview of income statement, balance sheet, and cash flow financials.
